Table 5 Therapy of 174 renal transplant recipients with mucormycosis
From: Mucormycosis in renal transplant recipients: review of 174 reported cases
Therapy | Patient number | Survived/total number |
|---|---|---|
Amphotericin B formulation | ||
Deoxycholate | 78/174(44.8%) | 37/78(47.4%) |
Lipid | 64/174(36.8%) | 47/64(73.4%) |
Posaconazole | 13/174(7.5%) | 12/13(92.3%) |
Itraconazole, voriconazole, fluconazole, encanocandins, and no antifungal therapy | 19/174(11.0%) | 4/19(21.1%) |
Surgery alone | 11/174(6.3%) | 4/11(36.4%) |
Surgery and antifungal therapy | 121/174(69.5%) | 85/121(70.2%) |
Antifungal alone | 34/174(19.5%) | 11/34(32.4%) |
None | 8/174(4.6%) | 0/8(0%) |